Rioux et al. explore the ways in which virtual overdose monitoring services and overdose detection technologies can help to expand the reach of 'traditional' harm reduction interventions whilst highlighting concerns —including related to privacy and surveillance.
Levenson et al. note how the overdose crisis in the United States is inextricably linked to wider systems of criminalisation and incarceration, calling for the abolition of policing and prisons in order to uproot structural causes of harm.
Drug Policy Alliance underscore how chronic underinvestment in public services and the criminalisation of social issues have fuelled several concurrent crises, calling for increased investment in jobs, education, housing, and health care.
EuroNPUD advocate for peer-led harm reduction delivered by, with and for people who use drugs and provide technical resources that support the delivery of peer-led harm reduction by drug user organisations and peer work projects.
Van Amsterdam et al. present the first set of empirical findings relating to generic drug legislation in the UK and Germany, revealing it to be largely ineffective in counteracting NPS use and causing increased public health problems.
Paradise et al. underscore the importance of incorporating the voices of people experiencing homelessness into the development of housing and substance use treatment programs, in order to reduce the risk of overdose and protect those most vulnerable to the intersecting housing and opioid overdose crises.
Harm Reduction International expose the large sums of aid being spent on drug prohibition worldwide, calling on governments and donors to divest from punitive policies and invest in health and human rights.
Hayashi et al. reveal that despite the enactment of a depenalisation policy in Vancouver, police continued to seize illicit drugs from people who use drugs, calling for abolition of this harmful discretionary policing practice.
OHCHR present their report to the Human Rights Council on the impact of the world drug problem on human rights, urging policymakers to shift towards a health and human-rights centred approach to drug policy.